Linked Data API

Show Search Form

Search Results

1701855
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Pregnancy: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what information her Department holds on the number of non-invasive pre-natal tests branded as NIFTY and manufactured by BGI Group have been sold in the UK. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 22292 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-24more like thismore than 2024-04-24
answer text <p>The Department and NHS England do not hold information on the sales within the United Kingdom of the non-invasive pre-natal tests branded as NIFTY, manufactured by BGI Group. The NHS Supply Chain, who manage the sourcing, delivery, and supply of healthcare products, services, and food for National Health Service trusts and healthcare organisations across England, develop procurement frameworks which enable NHS organisations to buy goods and services from suppliers. NHS Supply Chain has confirmed that non-invasive pre-natal tests branded as NIFTY and manufactured by BGI Group, are not on their procurement framework.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-04-24T15:30:31.597Zmore like thismore than 2024-04-24T15:30:31.597Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
3960
label Biography information for Henry Smith more like this
1701858
registered interest false more like this
date remove filter
answering body
Cabinet Office more like this
answering dept id 53 more like this
answering dept short name Cabinet Office more like this
answering dept sort name Cabinet Office more like this
hansard heading Genomics: National Security more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Minister for the Cabinet Office, with reference to the Deputy Prime Minister's oral statement of 11 September 2023 on Security Update, Official Report, column 673, whether he has made an assessment with Cabinet colleagues of the potential merits of designating the genomics sector as Critical National Infrastructure. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 22293 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-25more like thismore than 2024-04-25
answer text <p>The genomics sector is not currently designated as Critical National Infrastructure (CNI). There is a strict framework for classification: CNI assets and systems are those that have been assessed as having a significant and catastrophic impact to the functioning of the UK – either through the loss of life or limb, on the economy, or national security, defence or the functioning of the state – should they be disrupted or compromised. The threshold is a high bar so that resources are focused on the highest priority, and most critical, assets and systems.</p><p>There are strong and sufficient provisions protecting UK genomics databases, including through the UK Data Protection Act (2018), which delivers a data protection framework tailored to the needs of our criminal justice agencies and intelligence services. The relevant genomics data is additionally held within Secure Data Environments, affording further security protections.</p><p>As with all parts of the CNI landscape, we commit to keeping this position under review.</p><p><strong></strong><br><br></p>
answering member constituency Salisbury more like this
answering member printed John Glen more like this
question first answered
less than 2024-04-25T16:32:15.25Zmore like thismore than 2024-04-25T16:32:15.25Z
answering member
4051
label Biography information for John Glen more like this
tabling member
3960
label Biography information for Henry Smith more like this
1701860
registered interest false more like this
date remove filter
answering body
Department for Science, Innovation and Technology more like this
answering dept id 216 more like this
answering dept short name Science, Innovation and Technology more like this
answering dept sort name Science, Innovation and Technology more like this
hansard heading Genomics: China more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 26 February 2024 to Question 14260 on Genomics: China, whether the programme of work to assess risks from biological data will include a review of (a) BGI Group, (b) MGI Tech and (c) other companies linked to the Chinese state. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 22294 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-25more like thismore than 2024-04-25
answer text <p>Through the delivery of our Biological Security Strategy, the Government is committed ensuring the UK is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy and build confidence in sharing personal data to improve health outcomes in the UK and across the world. This review covers the extent to which the UK shares data with certain companies.</p><p>Currently, organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas. These organisations consult with security personnel on a regular basis to ensure partnerships are aligned with our national security interests.</p>
answering member constituency Arundel and South Downs more like this
answering member printed Andrew Griffith more like this
question first answered
less than 2024-04-25T08:43:41.057Zmore like thismore than 2024-04-25T08:43:41.057Z
answering member
4874
label Biography information for Andrew Griffith more like this
tabling member
3960
label Biography information for Henry Smith more like this